Review




Structured Review

Genzyme ccl2 antibody genzyme techne
Chemokines and chemokine receptors with potential for BD laboratory biomarkers.
Ccl2 Antibody Genzyme Techne, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccl2+antibody+genzyme+techne/pmc09889923-74-17-23?v=Genzyme
Average 90 stars, based on 1 article reviews
ccl2 antibody genzyme techne - by Bioz Stars, 2026-08
90/100 stars

Images

1) Product Images from "Chemokines and chemokine receptors in Behçet’s disease"

Article Title: Chemokines and chemokine receptors in Behçet’s disease

Journal: Frontiers in Immunology

doi: 10.3389/fimmu.2023.1109147

Chemokines and chemokine receptors with potential for BD laboratory biomarkers.
Figure Legend Snippet: Chemokines and chemokine receptors with potential for BD laboratory biomarkers.

Techniques Used: Biomarker Discovery, Activity Assay, Clinical Proteomics



Similar Products

90
Genzyme ccl2 antibody genzyme techne
Chemokines and chemokine receptors with potential for BD laboratory biomarkers.
Ccl2 Antibody Genzyme Techne, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccl2+antibody+genzyme+techne/pmc09889923-74-17-23?v=Genzyme
Average 90 stars, based on 1 article reviews
ccl2 antibody genzyme techne - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Chemokines and chemokine receptors with potential for BD laboratory biomarkers.

Journal: Frontiers in Immunology

Article Title: Chemokines and chemokine receptors in Behçet’s disease

doi: 10.3389/fimmu.2023.1109147

Figure Lengend Snippet: Chemokines and chemokine receptors with potential for BD laboratory biomarkers.

Article Snippet: In addition, many strategies that target the chemokine–chemokine receptor system, including some small molecule blockers and antibodies [the CXCL10 antibody (MDX-1100), CCL2 antibody (Genzyme Techne) and CXCR4 inhibitor (AMD3100)] for common autoimmune diseases (such as rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus), have been developed and studied in preclinical and clinical trials with effective outcomes ( ).

Techniques: Biomarker Discovery, Activity Assay, Clinical Proteomics